Sinopharm Group announces plans to divest its medical management unit holding multiple state-owned hospitals.
According to Huxiu, Sinopharm Group plans to divest 70% of its stake in Sinopharm Medical Management Co., Ltd., a platform holding multiple state-owned hospitals. The company reported revenue of 3.112 billion yuan in 2025 and 1.449 billion yuan in the first half of 2026, while operating at a slight loss.
Key facts
- 01The Beijing Equity Exchange disclosed on September 18 that two platforms under Sinopharm Group intend to transfer the 70% equity stake in a package.
- 02Sinopharm Medical Management comprises five sectors, including Sinopharm Medical, which holds tertiary hospitals such as Xinxiang Central Hospital and Sinopharm Dongfeng General Hospital.
- 03The formal transfer floor price for the equity has not yet been disclosed.
AI-generated from the sources below. Always check the originals.
How each country tells it
So far our sources show coverage from one country. Perspectives appear once we find reports from a second country.
Sources
Summaries are AI-generated from the linked sources and may contain errors; always check the originals. We summarise and link; we never republish articles. Photos come from openly licensed libraries, official publicity material and brand logos, credited to their sources. If you own an image and want it credited differently or removed, email info@coda.news and we will act promptly.
- 141家国企医院，又要“再卖一次” · 虎嗅